Senores Pharmaceuticals Achieves 52-Week High Amid Market Volatility and Sector Outperformance
Senores Pharmaceuticals has achieved a new 52-week high of Rs. 715.8, reflecting a significant milestone for the small-cap company in the Pharmaceuticals & Biotechnology sector. The stock has shown a trend reversal after two days of decline and is currently trading above multiple moving averages, indicating strong performance.
Senores Pharmaceuticals has made headlines today as its stock price reached a new 52-week high of Rs. 715.8, marking a significant milestone for the small-cap company in the Pharmaceuticals & Biotechnology sector. This surge represents an 11.33% increase during the trading session, allowing the stock to outperform its sector by 8.95%. After experiencing two consecutive days of decline, Senores Pharmaceuticals has shown a trend reversal, indicating a potential shift in market sentiment. The stock has exhibited high volatility today, with an intraday volatility of 7.76%, reflecting the dynamic nature of trading activity. Notably, Senores Pharmaceuticals is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong performance relative to its historical price trends.
In the broader market context, the Sensex has rebounded sharply after a negative opening, recovering 412.87 points to trade at 81,033.12. Despite this recovery, the Sensex has experienced a decline of 1.78% over the past three weeks. In comparison, Senores Pharmaceuticals has maintained a stable performance over the past year, showing a 0.00% change, while the Sensex has decreased by 0.40%.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
